A Wnt- and beta -catenin-dependent pathway for mammalian cardiac myogenesis - PubMed (original) (raw)
A Wnt- and beta -catenin-dependent pathway for mammalian cardiac myogenesis
Teruya Nakamura et al. Proc Natl Acad Sci U S A. 2003.
Abstract
Acquisition of a cardiac fate by embryonic mesodermal cells is a fundamental step in heart formation. Heart development in frogs and avians requires positive signals from adjacent endoderm, including bone morphogenic proteins, and is antagonized by a second secreted signal, Wnt proteins, from neural tube. By contrast, mechanisms of mesodermal commitment to create heart muscle in mammals are largely unknown. In addition, Wnt-dependent signals can involve either a canonical beta-catenin pathway or other, alternative mediators. Here, we tested the involvement of Wnts and beta-catenin in mammalian cardiac myogenesis by using a pluripotent mouse cell line (P19CL6) that recapitulates early steps for cardiac specification. In this system, early and late cardiac genes are up-regulated by 1% DMSO, and spontaneous beating occurs. Notably, Wnt3A and Wnt8A were induced days before even the earliest cardiogenic transcription factors. DMSO induced biochemical mediators of Wnt signaling (decreased phosphorylation and increased levels of beta-catenin), which were suppressed by Frizzled-8Fc, a soluble Wnt antagonist. DMSO provoked T cell factor-dependent transcriptional activity; thus, induction of Wnt proteins by DMSO was functionally coupled. Frizzled-8Fc inhibited the induction of cardiogenic transcription factors, cardiogenic growth factors, and sarcomeric myosin heavy chains. Likewise, differentiation was blocked by constitutively active glycogen synthase kinase 3beta, an intracellular inhibitor of the Wntbeta-catenin pathway. Conversely, lithium chloride, which inhibits glycogen synthase kinase 3beta, and Wnt3A-conditioned medium up-regulated early cardiac markers and the proportion of differentiated cells. Thus, Wntbeta-catenin signaling is activated at the inception of mammalian cardiac myogenesis and is indispensable for cardiac differentiation, at least in this pluripotent model system.
Figures
Figure 1
Wnt3A and Wnt8 are early responses in differentiating P19CL6 cells. (A) Gene expression was determined by QRT-PCR, normalized to GAPDH, and represented as relative copy number. (B) Western blot, showing induction of GATA4 and sarcomeric MHCs vs. tubulin as the control. (C) Immunocytochemistry, showing induction of sarcomeric MHCs. Cells were cultivated for 12 days with (Right) or without (Left) 1% DMSO, and stained with MF20 (red) and 4′,6-diamidino-2-phenylindole (blue). (Bar = 50 μm.) (D) FGF8 expression by RT-PCR.
Figure 2
The Wnt/β-catenin-signaling pathway is activated at the onset of cardiac myogenesis. (A) Increased soluble β-catenin. Cells were treated with (+) or without (−) 1% DMSO for 3 days. The cytosolic fraction was subjected to Western blot analysis. β-Catenin was specifically decreased by Fz-8/Fc, an extracellular antagonist of Wnt signaling. (B) Decreased phosphorylated β-catenin and increased total β-catenin in whole-cell lysates. Cells were cultured as in A and Western blotting was done by using Abs to phospho-β-catenin (Top) and total β-catenin (Middle). (C) Decreased phosphorylated β-catenin (green), shown by immunostaining. (Left) Without DMSO. (Right) With DMSO. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (blue). (Bar = 50 μm.) (D) TCF/lymphoid enhancer factor-dependent transcription. Cells were cultured ± DMSO and transfected with TOPFLASH or FOPFLASH (inactive, mutant TCF sites) along with pRL-CMV. Luciferase activity was determined after 4 days of treatment.
Figure 3
The Wnt/β-catenin-signaling pathway was required for cardiac differentiation. (A) Fz-8/Fc suppresses the induction of GATA4, TBX5, BMP2, BMP4, FGF8, and α-MHC, determined by QRT-PCR. Cells were treated with DMSO plus diluent or 200 ng/ml Fz-8/Fc. Equivalent results were obtained by using Fz-4/Fc. (B Left) Fz-8/Fc suppresses the induction of sarcomeric MHC protein. (Right) Constitutively active GSK-3β (GSK3βA9) suppresses the induction of sarcomeric MHC protein. (Bar = 25 μm.) (C) GSK3βA9 inhibits Wnt3A-induced TCF transcriptional activity. 293T cells were cotransfected with PGK-neo, PGK-Wnt3A, and pcDNA3-GSK-3βA9-HA as shown, plus the TOPFLASH and pRL-CMV reporter genes. (D) GSK-3βA9-HA expression in stably transformed P19CL6 cells, by RT-PCR. Cells were stably transfected with the pcDNA3 expression vectors shown. Plasmid, 5 ng of pcDNA3-GSK-3βA9-HA as template. (E) GSK-3βA9 suppresses DMSO-induced cardiac gene expression.
Figure 4
The Wnt/β-catenin-signaling pathway enhances cardiac myogenesis. (A) Wnt3A CM increases TCF-dependent transcription. P19CL6 cells cotransfected with TOPFLASH and pRL-CMV were assayed after 18 h in Wnt3A or control (neo) CM. (B) Wnt3A CM induces cardiac-specific markers (0–15 days) and BMPs (6 days), shown by QRT-PCR. Wnt3A CM induces sarcomeric MHC, shown by immunostaining. (Bar = 50 μm.) (C) LiCl enhances cardiomyogenesis. Induction of cardiac-specific markers was analyzed by QRT-PCR (day 5). NaCl was added as the control.
Similar articles
- Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA, Kittrell FS, Medina D, Butel JS. Hollmann CA, et al. Oncogene. 2001 Nov 15;20(52):7645-57. doi: 10.1038/sj.onc.1204980. Oncogene. 2001. PMID: 11753642 - The Wnt/beta-catenin pathway directs neuronal differentiation of cortical neural precursor cells.
Hirabayashi Y, Itoh Y, Tabata H, Nakajima K, Akiyama T, Masuyama N, Gotoh Y. Hirabayashi Y, et al. Development. 2004 Jun;131(12):2791-801. doi: 10.1242/dev.01165. Epub 2004 May 13. Development. 2004. PMID: 15142975 - Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
Liu BY, Kim YC, Leatherberry V, Cowin P, Alexander CM. Liu BY, et al. Oncogene. 2003 Dec 18;22(58):9243-53. doi: 10.1038/sj.onc.1207217. Oncogene. 2003. PMID: 14681683 - An arrow for wingless to take-off.
Pandur P, Kühl M. Pandur P, et al. Bioessays. 2001 Mar;23(3):207-10. doi: 10.1002/1521-1878(200103)23:3<207::AID-BIES1029>3.0.CO;2-0. Bioessays. 2001. PMID: 11223876 Review.
Cited by
- Revisiting the Role of Autophagy in Cardiac Differentiation: A Comprehensive Review of Interplay with Other Signaling Pathways.
Kolahdouzmohammadi M, Kolahdouz-Mohammadi R, Tabatabaei SA, Franco B, Totonchi M. Kolahdouzmohammadi M, et al. Genes (Basel). 2023 Jun 24;14(7):1328. doi: 10.3390/genes14071328. Genes (Basel). 2023. PMID: 37510233 Free PMC article. Review. - Activation of Wnt/β-Catenin Signaling Involves 660 nm Laser Radiation on Epithelium and Modulates Lipid Metabolism.
Xiao Q, Wang L, Zhang J, Zhong X, Guo Z, Yu J, Ma Y, Wu H. Xiao Q, et al. Biomolecules. 2022 Sep 29;12(10):1389. doi: 10.3390/biom12101389. Biomolecules. 2022. PMID: 36291598 Free PMC article. - The negative regulation of gene expression by microRNAs as key driver of inducers and repressors of cardiomyocyte differentiation.
Cianflone E, Scalise M, Marino F, Salerno L, Salerno N, Urbanek K, Torella D. Cianflone E, et al. Clin Sci (Lond). 2022 Aug 31;136(16):1179-1203. doi: 10.1042/CS20220391. Clin Sci (Lond). 2022. PMID: 35979890 Free PMC article. Review. - The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells.
Soma Y, Morita Y, Kishino Y, Kanazawa H, Fukuda K, Tohyama S. Soma Y, et al. Front Cardiovasc Med. 2021 Dec 8;8:774389. doi: 10.3389/fcvm.2021.774389. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34957258 Free PMC article. Review. - Context Matters-Why We Need to Change From a One Size Fits all Approach to Made-to-Measure Therapies for Individual Patients With Pancreatic Cancer.
Sankarasubramanian S, Pfohl U, Regenbrecht CRA, Reinhard C, Wedeken L. Sankarasubramanian S, et al. Front Cell Dev Biol. 2021 Nov 4;9:760705. doi: 10.3389/fcell.2021.760705. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34805167 Free PMC article. Review.
References
- Garcia-Martinez V, Schoenwolf G C. Dev Biol. 1993;159:706–719. - PubMed
- Harvey R P, Rosenthal N, editors. Heart Development. San Diego: Academic; 1998.
- Beddington R S, Robertson E J. Cell. 1999;96:195–209. - PubMed
- Schultheiss T M, Burch J B, Lassar A B. Genes Dev. 1997;11:451–462. - PubMed
- Eisenberg C A, Eisenberg L M. Dev Dyn. 1999;216:45–58. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources